• ngwaahịa_banner

COVID-19/Flu A&B Immunoassay ngwa ngwa maka nchọpụta ozugbo

Nkọwa dị mkpirikpi:

Ụdị Nasalpharyngeal swab, Oropharyngeal swab Usoro Cassette
Trans.& Sto.Okpomọkụ 2-30℃ / 36-86℉ Oge ule Nkeji 15
Nkọwapụta 1 Nnwale/Kit;5 Nnwale/Kit;25 Nnwale/Kit

Nkọwa ngwaahịa

Mkpado ngwaahịa

COVID-19/Flu A&B Ngwa ngwa Immunoassay maka nchọpụta ozugbo,
COVID-19/Flu A&B Immunoassay ngwa ngwa maka nchọpụta ozugbo,

Nkọwa ngwaahịa

Ezubere iji
A ga-eji SARS-CoV-2 na Influenza A/B Antigen Combo Ngwa ngwa ule ngwa ngwa (Lateral chromatography) yana ngosipụta ụlọ ọgwụ yana nsonaazụ nyocha ụlọ nyocha ndị ọzọ iji nyere aka na nyocha nke ndị ọrịa a na-enyo enyo SARS-CoV-2 ma ọ bụ Influenza A. / B ọrịa.Naanị ndị ọkachamara ahụike ga-eji ule a.Ọ na-enye naanị nsonaazụ nyocha mbụ yana a ga-eme ụzọ nyocha ọzọ akọwapụtara iji nweta nkwenye nke ọrịa SARS-CoV-2 ma ọ bụ Influenza A/B.Maka iji naanị ọkachamara.

Ụkpụrụ ule
SARS-CoV-2 & Influenza A/B Antigen Combo Ngwa ngwa ule ngwa ngwa (Lateral chromatography) bụ ihe na-erugharị n'akụkụ chromatographic immunoassay.Ọ nwere nsonaazụ abụọ Windows.N'aka ekpe maka SARS-CoV-2 antigens.Ọ nwere ahịrị abụọ etinyere mbụ, “T” ahịrị nnwale na “C” akara akara na akpụkpọ ahụ nitrocellulose.N'aka nri bụ windo nsonaazụ nke FluA/FluB, ọ nwere ahịrị atọ etinyegoro, "T1" FluA Test line, "T2" FluB Test line na "C" akara akara na nitrocellulose membrane.

Isi ọdịnaya

Edepụtara ihe ndị enyere na tebụl.

Aha ngwaahịa Nwamba.Mba Nha Ụdị Ndụ shelf Trans.& Sto.Okpomọkụ

SARS-Cov-2 & Influenza A&B Antigen Rapid Test Kit (Immunochromatographic Assay)

B005C-01 1 ule/kit Nasalpharyngeal swab, Oropharyngeal Swab Ọnwa 24 2-30℃ / 36-86℉
B005C-05 5 ule/kit
B005C-25 25 ule/kit

Usoro ọrụ

  • Nzọụkwụ 1: Nlereanya

Nzọụkwụ 1- Nlereanya

Tụgharịa isi onye ọrịa azụ 70 degrees.Jiri nlezianya tinye swab n'ime imi ruo mgbe swab rutere n'azụ imi.Hapụ swab n'oghere imi ọ bụla maka 5 sekọnd iji nweta ihe nzuzo.

  • Nzọụkwụ 2: Nnwale

Nnwale

1. Wepu tube mmịpụta na kit na igbe ule na akpa ihe nkiri site na ịdọwa notch.Tinye ha n'ụgbọ elu kwụ ọtọ.

2. Mgbe ịlelechara, gbanye smear n'okpuru ọkwa mmiri mmiri nke ihe ntinye ihe nlele, gbanwee ma pịa ugboro 5.Na-emikpu oge nke smear dịkarịa ala 15s.

3. Wepu swab ma pịa nsọtụ nke tube iji kpochapụ mmiri mmiri dị na swab.Tụba swab ahụ n'ime ihe mkpofu dị ize ndụ.

4. Idozi mkpuchi pipette nke ọma n'elu ọkpọ mmiri ahụ.Mgbe ahụ jiri nwayọọ tụgharịa tube mmịpụta ahụ ugboro 5.

5. Nyefee 2 ruo 3 tụlee (ihe dị ka 100 ul) nke ihe nlele ahụ na nlele nlele nke eriri ule wee malite ngụ oge.Rịba ama: ọ bụrụ na ejiri ihe nlele oyi kpọnwụrụ, ihe nlele ahụ ga-enwerịrị okpomọkụ ụlọ.

  • Nzọụkwụ 3: Ịgụ

Nkeji 15 ka e mesịrị, gụọ nsonaazụ ya na anya.(Rịba ama: agụla nsonaazụ mgbe nkeji iri abụọ gachara!)

Nkọwapụta nsonaazụ

Nsonaazụ 1
Nsonaazụ 2

1.SARS-CoV-2 Nsonaazụ Dị Mma

Akara agba na-apụta na ahịrị nnwale (T) na akara njikwa (C).Ọ na-egosi a

Nsonaazụ dị mma maka SARS-CoV-2 antigens na ụdị ahụ.

2.FluA Nsonaazụ Dị Mma

Akara agba na-apụta na ahịrị nnwale (T1) na akara njikwa (C).Ọ na-egosi

nsonaazụ dị mma maka FluA antigens n'ụdị.

3.FluB Nsonaazụ Dị Mma

Akara agba na-apụta na ahịrị nnwale (T2) na akara njikwa (C).Ọ na-egosi

nsonaazụ dị mma maka FluB antigens na ụdị.

4.Ngative Result

Otu eriri agba na-apụta na ahịrị njikwa (C) naanị.Ọ na-egosi na

itinye uche nke SARS-CoV-2 na FluA/FluB antigens adịghị ma ọ bụ

n'okpuru njedebe nchọpụta nke ule.

5. Nsonaazụ ezighi ezi

Enweghị eriri nwere agba a na-ahụ anya na-egosi na akara njikwa ka emechara ule ahụ.Nke

O nwere ike ọ gaghị agbaso ntuziaka ahụ nke ọma ma ọ bụ nwee ike ịme ule ahụ

njọ.A na-atụ aro ka a nwaleghachi ihe nlele ahụ.

Ozi ịtụ

Aha ngwaahịa Nwamba.Mba Nha Ụdị Ndụ shelf Trans.& Sto.Okpomọkụ
SARS-CoV-2 & Influenza A/B Antigen Combo Ngwa ngwa ule ngwa ngwa (chromatography ikpeazụ) B005C-01 1 ule/kit Nasalpharyngeal swab Ọnwa 18 2-30℃ / 36-86℉
B005C-05 5 ule/kit
B005C-25 25 ule/kit

Nnwale COVID-19/Flu A&B bụ immunoassay na-erugharị n'akụkụ ezubere maka ngwa ngwa in vitro, nke nwere otu oge.
nchọpụta na ọdịiche nke nucleocapsid antigen si SARS-CoV-2, influenza A na / ma ọ bụ influenza B ozugbo site na ihu.
ụdị imi ma ọ bụ nasopharyngeal swab enwetara site na ndị mmadụ n'otu n'otu, ndị a na-enyo enyo na ha nwere nje virus nke iku ume.
kwekọrọ na COVID-19 site n'aka onye na-ahụ maka ahụike ha, n'ime ụbọchị ise mbụ nke mmalite nke mgbaàmà.Clinical akara na
mgbaàmà nke ọrịa nje na-eku ume n'ihi SARS-CoV-2 na influenza nwere ike ịbụ otu ihe ahụ.Nnwale bụ naanị na ụlọ nyocha
enwetara ikike n'okpuru mmezi mmezi ụlọ nyocha nke 1988 (CLIA), 42 USC §263a, na-ezute
ihe achọrọ iji mee ule mgbagwoju anya dị oke oke ma ọ bụ nke agbaghara.Enyere ngwaahịa a ikike maka ojiji na ebe nlekọta
(POC), ntụgharị, na ntọala nlekọta ndị ọrịa na-arụ ọrụ n'okpuru Asambodo Waiver CLIA, Asambodo nnabata, ma ọ bụ Asambodo nke
nzere ntozu.


  • Nke gara aga:
  • Osote:

  • Dee ozi gị ebe a ziga anyị ya